Free tool
Heavily traded stocks
We cover 8 companies whose typical session turns over more than $10.00M. The median market value in the group is $104.68B. Across the group, the median move over the past trading day is +1.90%. Price change over the past year runs from −19.9% to +73.7% across the middle 80 percent of the group, with a median of +5.9%.
Other lists in this group
Table
8 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| MPAL.L | MedPal AI PLC | $44.20M | Micro cap | −40.00% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.